An innovative colon inflammation-targeting platform for ulcerative colitis treatment
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Due to targeting, we show that a single oral administration of Lipo-tm-HA at a dose of 10 milligrams per kilogram is superior in efficacy compared with daily treatment with free tofacitinib in a dextran sodium sulfate–induced colitis model.
Appeared: Sunday, October 25. Science Advances. Peer-reviewed journal.